POPULARITY
Categories
Plug-in solar has the potential to change far more than how or where we install solar panels. I believe it could fundamentally change who gets to participate in the energy transition.I recently sat down with Stephan Scherer, Co-Founder and CEO of CraftStrom, who's spent nearly a decade helping pioneer the plug-in solar market—first in Europe, and now here in the United States. Stephan didn't simply watch this category emerge. He helped move it from a niche idea to a product you can buy off-the-shelf in mainstream retail stores like Aldi and Lidl.In this conversation, Stephan shares what his customers taught him as the market evolved, why the U.S. is now wrestling with many of the same questions Europe faced years ago, and what policymakers, utilities, retailers, installers, and manufacturers should be paying attention to as this category begins taking shape here at home.We also explore one of the biggest surprises from CraftStrom's own customer base: the people buying these systems aren't always who the solar industry expected. That raises a much bigger question about who traditional rooftop solar has been leaving behind—and whether plug-in solar could become an entirely new on-ramp to energy independence.Whether you're writing policy, designing energy products, selling residential solar, or simply curious about where customer-owned energy is headed next, this conversation offers a rare opportunity to learn from someone who's helped build this market from the very beginning—and why he believes plug-in solar is about to change everything.Are there other technologies you've scouted on the frontlines of the Clean Energy Revolution that you think we should be covering here on SunCast?Hit us up - team@suncast.me with your feedback & recommendations.If you want to connect with today's guest, you'll find links to their contact info in the show notes on the blog at https://suncast.media/episodes/.Our Platinum Presenting Sponsor for SunCast is CPS America!You can learn more about all the sponsors who help make this show free for you at www.suncast.media/sponsors.Remember, you can always find resources, learn more about today's guest and explore recommendations, book links, and more than 875 other founder stories and startup advice at www.suncast.media.Subscribe to Valence, our weekly LinkedIn Newsletter, and learn the elements of compelling storytelling: https://www.linkedin.com/newsletters/valence-content-that-connects-7145928995363049472/You can connect with me, Nico Johnson, on:Twitter - https://www.twitter.com/nicomeoLinkedIn - https://www.linkedin.com/in/nickalus
La 4T detiene a un ex gobernador… panista
Neste episódio, o Arcebispo destaca a figura de SãoBoaventura e exorta a conversão dos fiéis afastados da Igreja católica.
La presidenta y su agresividad con EU
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
O Arcebispo de São Paulo, Dom Odilo P. Scherer, medita a leitura do Evangelho do dia (Mt 9,18-26) e exorta os fiéis à confiança em Deus.
Die Diskussion um Pädiatrie und Generalistik kocht in sozialen Medien regelmäßig hoch – aber was steckt wirklich dahinter? In dieser Folge sprechen Francis, Jennifer Wellensiek und Kathrin Scherer offen darüber, was in der Ausbildung fehlt, was die Praxis bereits leistet und welche Lösungsstrukturen gerade entstehen.In dieser Folge:Was wirklich fehlt: Warum 120 Praxisstunden im pädiatrischen Setting nicht reichen – und warum ein Kindergarteneinsatz kein Ersatz istDas Curriculum-Problem: Schulinterne Lehrpläne werden nicht bundesweit geprüft, und das hat FolgenGute Einarbeitung als Modell: Wie das Clemens-Hospital in Münster neue Kolleg:innen ein Jahr lang strukturiert begleitetDie neue Spezialisierungsweiterbildung in NRW: Zwölf Monate, berufsbegleitend, bezahlt – und was das für die Praxis bedeutetWas es jetzt braucht: Bundeseinheitliche Standards, akademisierte Weiterbildungswege und eine Haltung, die Lernen nach dem Examen ermöglichtHintergründe und Shownotes zur Folge findest du hier.Wichtige Links:Zum JobboardZum EventkalenderSchau dir unseren neuen Videokurs an!Jetzt Übergabe Mitglied werdenÜbergabe bei Instagram
Los partidos nuevos
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Neste episódio, o Arcebispo de São Paulo , Dom Odilo P. Scherer, reflete sobre o legado de Madre Assunta, co-fundadora da congregação das irmãs scalabrinianas, uma missionária entre os órfãos, doentes e migrantes.
Neste episodio, o Arcebispo de São Paulo, Dom Odilo Pe. Scherer, comenta o Consistório, do qual participou, convocado pelo Papa Leão XIV. O encontro com os cardeais terminou com esperança renovada.
Morena y el 2027. ¿Habrá choque de trenes?
Ob im Büro oder der Fabrik – KI automatisiert immer mehr Aufgaben und verändert Jobs grundlegend. Wie können Unternehmen ihre Effizienz steigern und gleichzeitig Beschäftigte mitgenommen werden, damit sie im Wettbewerb nicht abgehängt werden? Scherer, Katja www.deutschlandfunk.de, Hintergrund
Antes de ser medalhista, recordista e um dos maiores nomes da natação brasileira, Fernando Scherer precisou enfrentar uma prova muito mais difícil: conhecer a si mesmo.No novo episódio do Interioriza na Copa, Izabella Camargo conversa com o eterno Xuxa sobre carreira, aposentadoria, identidade, depressão, saúde mental e o verdadeiro significado do sucesso.
O Arcebispo Metropolitano de São Paulo reflete sobre a vida e legado dos Santos João Fisher e Tomás More.
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Mundial 2026
Sheinbaum y el Mundial
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.
¿Hasta dónde llegará la CNTE?
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Scherer, Katja www.deutschlandfunk.de, Andruck - Das Magazin für Politische Literatur
La aprobación de Sheinbaum
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
¿Y dónde está la oposición?
3 - Meghalt Scherer Péter, és mi rá emlékeztünk by Balázsék
Scherer. Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
La falta de operadores en el gabinete de Sheinbaum
¿Qué pasos se debe dar para tratar de contener la crisis post Rocha Moya?
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Acusaciones contra Rocha Moya
6 - Mai felolvasónk: Scherer Péter Jászai Mari-díjas színész by Balázsék
Scherer, Katja www.deutschlandfunk.de, Wirtschaft am Mittag
Luisa María…. Y los enredos políticos de la 4T
La Luz del Mundo. Condenada en Estados Unidos, impune en México
Dean's Chat Learning Series hosts, Drs. Jensen and Richey, sit down with Dr. Warren Joseph, to discuss fungal infections and antifungal resistance. Below are some takeaway notes:1. Onycho.ID is the first and only Medicare (MolDx) approved, laboratory PCR test for the diagnosis on onychomycosis, developed and clinical validated by BakoDx2. Why choose Onycho.iD? Because it provides an unmatched approach for identifying the infectious agenta. Sensitivity: 92.6% Specificity: 100% (vs histopathology)b. Supports data-driven treatment decisions and improved patient outcomesc. 24-48 turn-around-timed. Detection of dermatophytes, non-dermatophytes, molds and yeastse. Cost-effective and eliminates unnecessary additional testing3. Identify Terbinafine Resistance using PCR Assaya. Trichophyton rubrum and Trichophyton mentagrophytes represents 59% of the organisms responsible for nail infectionsb. Terbinafine is the most common prescribed medicationc. Terbinafine resistance is on the rised. PCR testing (Onycho.ID) provides novel and specific real-time TaqMan PCR testing to detect 12 mutations of T. rubrum and T. mentorophytesWhat is MolDx?The MolDX (Molecular Diagnostic Services) Program is a Palmetto GBA-managed Medicare program that evaluates, registers, and determines coverage/reimbursement for molecular diagnostic tests. It ensures tests are clinically valid, assigns unique DEX Z-Codes for identification, and sets policies for over 28 states to ensure Medicare covers only medically necessary, evidence-based tests. MolDX States (Strict Molecular Testing Review)These states follow the MolDX Program run by Palmetto GBA, which requires DEX Z-codes and technical assessment for PCR tests.Southeast• Alabama• Georgia• Tennessee• North Carolina• South Carolina• Virginia• West VirginiaMidwest• Indiana• Michigan• Iowa• Kansas• Missouri• Nebraska• Kentucky• OhioWestern States• California• Arizona• Nevada• Utah• Oregon• Washington• Idaho• Montana• Wyoming• North Dakota• South Dakota• Alaska• HawaiiAdditional comments from Dr. Scherer, Bako Consultant - who will be joining us on a future episode:“The main benefit of Bako Diagnostics' screening and reflex PCR testing for nails is that it provides a very cost-effective method for PCR analysis. With this approach, the laboratory first performs a screening test. If a dermatophyte is detected during screening, only four PCR probes (cycles) are run in the reflex test, and the test is billed only for those probes.However, if a different type of fungus is identified during screening, the reflex test expands accordingly. For example, if a non-dermatophyte mold is suspected, the lab tests for seven different organisms. Similarly, if yeast is indicated, the reflex panel focuses on yeast organisms.The advantage of this screening-and-reflex algorithm is that the laboratory limits the number of DNA probes used to only the genus or group identified in the initial screening. This targeted approach reduces unnecessary testing and ultimately produces the lowest possible cost for PCR toenail diagnostics.”
Today's guests are Megan and Mike Scherer, co-founders of Worth the Wait, a nationwide oncofertility non-profit organization. After Mike's experience as a testicular cancer survivor and their own fertility issues, they wanted to offer hope and resources for others navigating the world of oncofertility. Worth the Wait's mission is to empower young adult cancer survivors on their path to parenthood. They provide financial support and educational resources for fertility treatments, adoption, and surrogacy while advocating for oncofertility within the healthcare system and beyond.Having both Mike and Megan as guests, we talk about cancer from both the patient and caregiver perspective, fertility issues from reproductive cancers, the families Worth the Wait has helped build, making their mission a family affair with their son Elliott, and so much more!!!This is a conversation that should happen so much more, especially in the young adult cancer space. Please share with those in your life that may be dealing with oncofertility concerns.Resources:Website: https://worththewaitcharity.com/Instagram: https://www.instagram.com/worththewaitcharity/Facebook: https://www.facebook.com/WorthTheWaitCharityLinkedIn: https://www.linkedin.com/company/79794452/Megan's LinkedIn: https://www.linkedin.com/in/meganscherer/Mike's LinkedIn: https://www.linkedin.com/in/mike-schererwtw/Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com
¿Es prescindible el PT?
¿Cuál es el futuro de la coalición gobernante?
Rebelión al interior de Morena
¿Reforma Electoral de Sheinbaum nacerá muerta?
¿Se aprobará la Reforma Electoral de Sheinbaum?
Grecia contraataca
El libro de Scherer y la respuesta de Sheinbaum al texto
Sheinbaum y el nepotismo
From Apple News In Conversation: Health and Human Services Secretary Robert F. Kennedy Jr. is one of the most influential — and controversial — figures in American public health. And some of the changes he’s pushing, especially around vaccines, have drawn sharp criticism and resistance from many scientific experts. In a recent Atlantic profile, staff writer Michael Scherer examined how Kennedy’s background, including immense privilege and trauma, has shaped the perspective he now brings to his role at HHS. Scherer interviewed and traveled with Kennedy to report his piece. He sat down with Apple News In Conversation host Shumita Basu to discuss Kennedy’s worldview and what it could mean for federal public-health policy.
Venezuela’s opposition leader made a daring escape to Oslo shortly after the Nobel Peace Prize award ceremony. The Wall Street Journal’s Vera Bergengruen details the perilous journey. Lawmakers in the Senate failed to pass separate bills aimed at easing health-insurance costs that are set to skyrocket at the end of the year. Axios reports on what happens next. The Atlantic’s Michael Scherer has spent hours talking to Robert F. Kennedy Jr. In this week’s Apple News In Conversation, Scherer explores how the health secretary’s past shaped who he is today. Plus, Indiana Republicans rejected Trump’s redistricting efforts, Kilmar Abrego Garcia was released from immigration detention, and Mickey Mouse is formally entering the AI world. Today’s episode was hosted by Shumita Basu.